These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model. Kühl JS, Sikic BI, Blume KG, Chao NJ. Exp Hematol; 1992 Oct; 20(9):1048-54. PubMed ID: 1468539 [Abstract] [Full Text] [Related]
8. Elimination of clonogenic tumor cells from bone marrow using methylprednisolone (MP) and etoposide VP16: an in vitro pharmacologic study. Miller G, Brashear T, Stone M, Fay J. Int J Cell Cloning; 1991 Sep; 9(5):503-10. PubMed ID: 1955738 [Abstract] [Full Text] [Related]
9. Comparative cytotoxicity of various drug combinations for human leukemic cells and normal hematopoietic precursors. Chang TT, Gulati S, Chou TC, Colvin M, Clarkson B. Cancer Res; 1987 Jan 01; 47(1):119-22. PubMed ID: 3466686 [Abstract] [Full Text] [Related]
10. In vitro evaluation of combination drug purging for autologous bone marrow transplantation. Jones RJ, Miller CB, Zehnbauer BA, Rowley SD, Colvin OM, Sensenbrenner LL. Bone Marrow Transplant; 1990 May 01; 5(5):301-7. PubMed ID: 2350626 [Abstract] [Full Text] [Related]
11. Combination chemotherapy and verapamil to purge drug resistant leukemia cells from human bone marrow. Cairo MS, Toy C, Sender L, Bennetts G, van de Ven C. Prog Clin Biol Res; 1990 May 01; 333():47-55. PubMed ID: 2308995 [No Abstract] [Full Text] [Related]
12. In vitro chemosensitivity of leukemic progenitor cells (AML-CFU) to a combination of mafosfamide lysine (ASTA-Z 7654) and etoposide (VP16-213). Deconinck E, Tamayo E, Hervé P. Bone Marrow Transplant; 1990 Jan 01; 5(1):13-8. PubMed ID: 2297586 [Abstract] [Full Text] [Related]
13. Growth of hemopoietic cells after incubation with VP 16-213. Schulze E, Hofmann U, Woetzel M, Helbig W. Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Jan 01; 116(3-4):591-6. PubMed ID: 2480314 [Abstract] [Full Text] [Related]
14. Etoposide as an in vitro purging agent for the treatment of acute leukemias and lymphomas in conjunction with autologous bone marrow transplantation. Ciobanu N, Paietta E, Andreeff M, Papenhausen P, Wiernik PH. Exp Hematol; 1986 Aug 01; 14(7):626-35. PubMed ID: 3525202 [Abstract] [Full Text] [Related]
15. Combinations of 4-hydroperoxycyclophosphamide (4-HC) and cisplatin for bone marrow purging in autologous marrow transplantation: an update. Peters RH, Brandon CS, Avila LA, Gale GR, Stuart RK. Prog Clin Biol Res; 1990 Aug 01; 333():57-68. PubMed ID: 2309001 [Abstract] [Full Text] [Related]
16. A combined approach for purging multidrug-resistant leukemic cell lines in bone marrow using a monoclonal antibody and chemotherapy. Aihara M, Aihara Y, Schmidt-Wolf G, Schmidt-Wolf I, Sikic BI, Blume KG, Chao NJ. Blood; 1991 May 01; 77(9):2079-84. PubMed ID: 1673356 [Abstract] [Full Text] [Related]
17. Evaluation of anticancer effects of newly synthesized dihydropyridine derivatives in comparison to verapamil and doxorubicin on T47D parental and resistant cell lines in vitro. Bazargan L, Fouladdel S, Shafiee A, Amini M, Ghaffari SM, Azizi E. Cell Biol Toxicol; 2008 Apr 01; 24(2):165-74. PubMed ID: 17805981 [Abstract] [Full Text] [Related]
18. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin. Rappa G, Lorico A, Sartorelli AC. Cancer Res; 1993 Nov 15; 53(22):5487-93. PubMed ID: 8106148 [Abstract] [Full Text] [Related]
19. Heat radiosensitization and the level of DNA polymerases alpha and beta of human colony-forming unit-granulocyte-macrophage and myeloid leukemias sensitive and resistant to chemotherapeutic agents. Mivechi NF, Miyachi H, Scanlon KJ. Cancer Res; 1990 Apr 01; 50(7):2044-8. PubMed ID: 2317794 [Abstract] [Full Text] [Related]
20. Evidence for transcriptional control of human mdr1 gene expression by verapamil in multidrug-resistant leukemic cells. Muller C, Goubin F, Ferrandis E, Cornil-Scharwtz I, Bailly JD, Bordier C, Bénard J, Sikic BI, Laurent G. Mol Pharmacol; 1995 Jan 01; 47(1):51-6. PubMed ID: 7838133 [Abstract] [Full Text] [Related] Page: [Next] [New Search]